98 related articles for article (PubMed ID: 19269730)
1. [Necrosis of the glans penis: a complication of an injection of buprenorphin in a opioid abuser].
Hornez E; Laroche J; Monchal T; Bourgouin S; Riviere P; Fournier R; Dantzer E
Ann Chir Plast Esthet; 2010 Apr; 55(2):159-61. PubMed ID: 19269730
[TBL] [Abstract][Full Text] [Related]
2. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
Clark NC; Lintzeris N; Muhleisen PJ
Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
[TBL] [Abstract][Full Text] [Related]
3. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets.
Feeney GF; Fairweather P
Drug Alcohol Rev; 2003 Sep; 22(3):359-61. PubMed ID: 15385230
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
Umbricht A; Huestis MA; Cone EJ; Preston KL
J Clin Psychopharmacol; 2004 Oct; 24(5):479-87. PubMed ID: 15349002
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an injection depot formulation of buprenorphine: placebo comparison.
Sigmon SC; Wong CJ; Chausmer AL; Liebson IA; Bigelow GE
Addiction; 2004 Nov; 99(11):1439-49. PubMed ID: 15500597
[TBL] [Abstract][Full Text] [Related]
6. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
7. [Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection].
Glaizal M; Lucciardi J; Tichadou L; Spadari M; Hayek-Lanthois M; Micallef J; de Haro L
Therapie; 2011; 66(6):545-7. PubMed ID: 22186079
[TBL] [Abstract][Full Text] [Related]
8. Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study.
Daulouède JP; Caer Y; Galland P; Villeger P; Brunelle E; Bachellier J; Piquet JM; Harbonnier J; Leglise Y; Courty P
J Subst Abuse Treat; 2010 Jan; 38(1):83-9. PubMed ID: 19800758
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis.
Peyrière H; Tatem L; Bories C; Pageaux GP; Blayac JP; Larrey D
Ann Pharmacother; 2009 May; 43(5):973-7. PubMed ID: 19383935
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
11. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous complications among i.v. buprenorphine users.
Ho RC; Ho EC; Mak A
J Dermatol; 2009 Jan; 36(1):22-9. PubMed ID: 19207433
[TBL] [Abstract][Full Text] [Related]
13. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
[TBL] [Abstract][Full Text] [Related]
14. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
Petersen H; Skauge L; Svejsø J; Ege PP
Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
[TBL] [Abstract][Full Text] [Related]
15. Infective endocarditis secondary to intravenous Subutex abuse.
Chong E; Poh KK; Shen L; Yeh IB; Chai P
Singapore Med J; 2009 Jan; 50(1):34-42. PubMed ID: 19224082
[TBL] [Abstract][Full Text] [Related]
16. Acute liver and renal failure during treatment with buprenorphine at therapeutic dose.
Zuin M; Giorgini A; Selmi C; Battezzati PM; Cocchi CA; Crosignani A; Benetti A; Invernizzi P; Podda M
Dig Liver Dis; 2009 Jul; 41(7):e8-e10. PubMed ID: 18294936
[TBL] [Abstract][Full Text] [Related]
17. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
18. [Is Subutex a magic drug?].
Krook AL
Tidsskr Nor Laegeforen; 2002 Dec; 122(30):2925-6. PubMed ID: 12569727
[No Abstract] [Full Text] [Related]
19. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine maintenance therapy hinders acute pain management in trauma.
Harrington CJ; Zaydfudim V
Am Surg; 2010 Apr; 76(4):397-9. PubMed ID: 20420250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
